CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-23 | Aryeh Jason Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,329 | $119.30 | $278K | 2,329 |
| 2016-05-20 | KOZARICH JOHN W Director | Gift | −350 | 43,361 | ||
| 2016-05-18 | Herman Melanie J Director of Accounting | Sale | −334 | $120.50 | $40K | 3,297 |
| 2016-05-06 | Aryeh Jason Director | Sale | −15,000 | $118.52 | $1.8M | 210,707 |
| 2016-05-05 | Aryeh Jason Director | Sale | −10,000 | $120.21 | $1.2M | 225,707 |
| 2016-05-02 | KOZARICH JOHN W Director | Sale | −800 | $121.45 | $97K | 43,911 |
| 2016-05-02 | KOZARICH JOHN W Director | Sale | −200 | $122.04 | $24K | 43,711 |
| 2016-04-06 | KOZARICH JOHN W Director | Sale | −5,000 | $115.00 | $575K | 44,711 |
| 2016-03-17 | FOEHR MATTHEW W President and COO | Exercise or conversion | +6,400 | $9.97 | $64K | 83,062 |
| 2016-03-17 | FOEHR MATTHEW W President and COO | Sale | −6,400 | $96.70 | $619K | 76,662 |
| 2016-03-17 | FOEHR MATTHEW W President and COO | Exercise or conversion | +2,250 | $9.97 | $22K | 78,912 |
| 2016-03-17 | FOEHR MATTHEW W President and COO | Exercise or conversion · Employee Stock Option (right to buy) | −6,400 | 85,610 | ||
| 2016-03-17 | FOEHR MATTHEW W President and COO | Exercise or conversion · Employee Stock Option (right to buy) | −2,250 | 83,360 | ||
| 2016-03-08 | Aryeh Jason Director | Sale | −500 | $102.49 | $51K | 235,707 |
| 2016-03-08 | HIGGINS JOHN L Chief Executive Officer | Exercise or conversion | +6,000 | $21.00 | $126K | 125,664 |
| 2016-03-08 | HIGGINS JOHN L Chief Executive Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −6,000 | 22,483 | ||
| 2016-03-07 | Aryeh Jason Director | Sale | −5,629 | $101.07 | $569K | 236,207 |
| 2016-03-07 | HIGGINS JOHN L Chief Executive Officer | Sale | −10,277 | $102.44 | $1.1M | 120,220 |
| 2016-03-07 | HIGGINS JOHN L Chief Executive Officer | Sale | −556 | $102.97 | $57K | 119,664 |
| 2016-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −2,492 | $85.97 | $214K | 130,497 |
Page 63 of 86 · 1,712 trades